Mediaboss Marketing

If you were running a business five years ago, you'll recall how this crazy social media thing played out.

First, a bunch of people calling themselves "social networking consultants" or "new media experts" or some such thing showed up with their palms out. After giving them some cash to do stuff you didn't understand, you decided they were mostly flim-flam artists (and we can hardly blame you) and sent them packing. But then, all of a sudden, everybody and their mother was on Twitter and you wondering how the heck it all happened so fast.

The truth is, nobody knew what to make of social networking sites when they first exploded a few years ago, let alone how to leverage them to help a business. But times have changed and the new media just isn't so new anymore—it's matured to the point that anybody with a product to sell, a service to offer, or a brand to promote has to be dedicating resources to their social messaging.

There's a reason Web 2.0 companies like online coupon site Groupon, and business networking service LinkedIn, and Facebook, the biggest fish of them all, are lining up to go public.

Social is big business. And not just for the providers of social media services, but for the companies that use platforms like Facebook and Twitter to increase awareness of what their selling as well.

A new infographic (below) from visual.ly serves up the goods on just how pervasive social networking has become and what a bonanza it can be for businesses that handle it the right way.

Now it's true that as with all marketing and advertising, it can be difficult to determine just what you're getting in return for dollars spent on social media. That's why you should probably be on the lookout for the next crop of consultants calling themselves "social marketing optimization experts" and such.

But in the meantime, digest these numbers: More than 80 percent of Americans participate in at least one social network and of those people, 53 percent follow a particular brand. That's roughly 130 million customers of some company or companies out there, and as visual.ly puts it, "Shouldn't it be yours?"

For the top stories in tech, follow us on Twitter at @PCMag.

View original post here:
Infographic: Can Your Business Afford to Ignore Social Media?

DOMINICAN REPUBLIC, Feb. 17, 2012 /PRNewswire/ -- The Dominican Republic Ministry of Tourism has taken the idea of social networking to a new level with their 2012 Dominican Republic social media-inspired ad campaign. In a follow-up to the successful 2011 launch of the social media-friendly website, the Dominican Republic Ministry of Tourism is introducing a multi-channel campaign featuring print, online and broadcast that generate engagement with consumers wherever they are in the world today, inspiring them to be social and share their unforgettable experience in Dominican Republic.

(Photo:  http://photos.prnewswire.com/prnh/20120217/CG55552)

Building on the destination's socially active fan base, the dynamic campaign provides a new perspective on the wide range of attractions, destinations, activities and services available to travelers. The creative approach behind the ads uses social networking as a metaphor to convey the message "You don't have to go far to be social," prompting the campaign's tagline, "Dominican Republic is Closer Than You Think."

"As Dominican Republic continues to thrive, we're distinguishing our enchanting destination and its vast tourism offerings from the competition," said Magaly Toribio, Vice Minister of International Promotion, Dominican Republic Ministry of Tourism. "We're ensuring that the campaign remains unforgettable, yet continues to capture Dominican Republic's one-of-a-kind offerings as the ads' captivating images trigger a need for experience and travel."

"The TV spots and ads rely on social media terms as metaphors for socializing with others about a vacation in Dominican Republic. The social interaction suggests the vacation as something worthy of a status update, both literally and in the Facebook sense. As the power of social media is undeniable, the ads blend technology and social interaction to create value, the value of sharing your experiences with others," added Toribio.

The Dominican Republic's award-winning website and the 2012 Social Campaign were developed by BVKmeka, the Dominican Republic Ministry of Tourism's U.S. and Hispanic marketing agency since 2004. The creative works seamlessly across computers, iPhones, iPads and other mobile devices, making it even easier to tell consumers that there is no better place to get closer and socialize in real life than in Dominican Republic.

The ads will be featured in magazines, broadcast, New York's Times Square billboards and online. The unique, attention-getting ads have already been broadcast on MEGA, as well as during the Serie del Caribe. To view the ads online, visit the website's media image gallery or video gallery.

About Dominican Republic
Dominican Republic's first tourist was Christopher Columbus in 1492. Rich in history, Dominican Republic has developed into a diverse destination offering both Dominican and European flavors to more than one million U.S. visitors each year. Named #1 Golf Destination in Caribbean & Latin America by the International Association of Golf Tour Operators, Dominican Republic boasts 28 designer golf courses, upscale resorts, pristine nature, and sophisticated cities and quaint villages filled with warm Dominican people.  Dominican Republic features the best beaches, fascinating history and culture, and is a chosen escape for celebrities, couples and families alike.  Visit Dominican Republic Ministry of Tourism's official website at: http://www.GoDominicanRepublic.com.

Follow us on Twitter @GoDomRep    
Like us on Facebook GoDominicanRepublic

Visit link:
New Dominican Republic Ad Campaign Goes Social

LONDON, February 17, 2012 /PRNewswire/ --

Millions of Britons are losing valuable sleep each night because they are addicted to social networking according to findings from a new sleep report.

Gone are the days when Britons liked nothing better then to be tucked up in bed with a mug of cocoa and a good book. In today's modern society, 72% of adults spend their time in bed before falling asleep updating or checking their friends status updates on Facebook.

The study commissioned by Travelodge hotels surveyed 6,000 adults to explore the nation's bedtime habits and key findings revealed we have become a nation of 'Online-A-Holics'. So bad is the problem that seven out of ten Britons are tweeting, poking, surfing and writing on each others' walls instead of going to sleep. In addition 18% of adults send a daily night-time tweet to their followers and one in five Britons catch up on tweets from their favourite celebrities and friends in bed.

On average each night Britons are spending 16 minutes in bed socially networking with pals - with the peak chatting time being 9.45pm. This time spent social networking is affecting Britons sleep quota as on average respondents reported they are getting just six hours and 21 minutes sleep per night. (This is one hour and 39 minutes below the recommended quota of eight hours of sleep per night.)

Dr Michael Hastings, an expert in sleep patterns and body clocks and a research scientist for the Medical Research Council at Addenbrooke's Hospital (Cambridge University Hospitals), said "From a sleep point of view, this news is not good at all as it's having a huge negative effect on people's sleep. Adults don't realise what impact using computers, mobile phones and other gadgets before falling sleep is having on their night's sleep. Being exposed to bright light from computer and mobile phone screens while in bed completely delays the brain and body's ability to get to sleep."

"As a result, people are not able to get to sleep as quickly as they should and aren't getting the required amount of sleep they need each night. A lot of people think that when they go to sleep their brain is turned off but that is not the case. The brain simply engages in a different activity where it stores important memories and gets rid of information that is not needed. If people aren't getting enough sleep each night their long-term memory is most definitely being affected and using social networking sites and technology before they go to sleep is worsening this."

"The sad thing is social networking is doing exactly what it was invented for - to grab people's attention and make them addicted.

Corinne Sweet, Psychologist, comments on the research findings: "We have become a nation of 'online-a-holics'. This addiction for social networking supports Maslow's theory of humans having three basic needs. One of these being the need for love, affection, belonging and self-worth and Facebook provides the perfect solution to fulfil this requirement. By socially networking we can fulfil our need to communicate and share our news in one hit with all of our contacts across the world 24/ 7 and obtain a comprehensive snapshot of what they are up to at any given time."

"Like all things there is a time and place and social networking should not take place between the sheets as it can be detrimental to our well being. By texting, tweeting, surfing and writing on our walls in bed we are nodding off with a busy mind which impacts upon our quality of sleep during the night. Bedtime should be associated with calming down and chilling out with a good book, listening to easy music, catching up with your partner or enjoying a love-making session in order to get a night of deep, nourishing sleep. Make time earlier in the evening for social networking as it will help you distress after a hard day and prepare you for bedtime".

Further research findings revealed that 65% respondents stated the very last thing they do before nodding off at night is to check their mobile phone for text messages. On average Britons will spend around nine minutes every night texting before falling asleep. Four out of ten adults reported they have a regular text communication with friends in bed every night.

So bad is the obsession with bed-texting that 20% of Britons surveyed confessed they have stopped mid-way whilst making love with their partner to check on an incoming text message.

Corinne Sweet, Psychologist said: "'No sex, Im texting' is the new British bedtime motto, it seems but couples need to be aware it can feel quite insulting to come second (as it were) to a text which can result in serious problems within a relationship. It's a good idea for love and intimacy to really blossom, if all mobiles and laptops can be left out of the boudoir, at least during love-making. Nothing is more annoying than the constant bleep of electronics to interrupt your night-time bliss".

Twenty seven per cent of adults surveyed also reported they are regularly awoken during the night by an incoming text message. Whilst a quarter of workers (25%) reported they frequently get a late night work related text from their boss.

Fifty one per cent of British adults surveyed stated the very first thing they do when they wake up - before even getting out of bed is to check their mobile phone for new texts or emails. One in ten respondents reported they will respond to any texts that have come through the night before getting out of bed.

As well as socially networking, a quarter of the nation (25%) does their weekly grocery shopping between the sheets. Whilst one in ten adults settles any outstanding bills online before nodding off. Over a third of the nation (35%) likes to surf celebrity news websites in bed for the latest showbiz gossip before slumbering.

With the festive season fast approaching 47% of respondents reported they are spending their time before falling asleep shopping for Christmas presents and making the necessary festive season arrangements.

One in ten Singletons surveyed admitted they like to check out online dating websites before falling asleep in the hope of finding their perfect partner.

The study also revealed the timehonoured, faithful alarm clock is set to become obsolete with 84% of adults now using their mobile phone as an alarm clock to help wake them up in the morning. In contrast in 2008 only 34%* of Britons used their mobile phone as a wake-up call. On average 36 of adults will get out of bed immediately once the alarm goes off whilst 42% like to press the snooze button a couple of times.

One in ten adults will set their daily alarm half an hour earlier than they need to get - so that have 30mins of snooze time every day.

Travelodge Sleep Director, Leigh McCarron said: "Alarm clocks have been shown to cause heart rhythm irregularities which can cause a heart attack. The alarm clock's strident ringing tone can be a shock to the body and mind. My recommendation is to wake up naturally as the awakening is part of a natural sleep-wake cycle and it can help you feel less groggy. Make your last thought before sleeping to be your intention to wake up at a particular time and sleep in complete darkness to aid a natural wake-up call.

About Travelodge:

The first budget hotel brand to launch in the UK in 1985, Travelodge now operates over 490 hotels and over 35,400 rooms across the UK, Ireland (11) and Spain (4). Travelodge plans to grow its estate to 1,100 hotels and 100,000 rooms by 2025. Over 13 million people stayed with Travelodge last year and 90% of reservations are currently made online at travelodge.co.uk, where room rates start at £19 per night. The chain employs over 6,000 staff.

For further information, please contact: Emma Arthurs, T: +44(0)1844-358703

Continued here:
Travelodge Sleep Report Shows Bedtime Social Networking Causes Sleep Deprivation Epidemic Across Britain

How do you find good stocks for great short-term trading opportunities? Do you hunt for value, growth or price momentum?

I look for all three, but with a twist that gives me an added "edge". I want to buy solid growth stocks after the market has "temporarily" and irrationally thrown them out with the bath water. If I am right that the selling insanity is temporary, I am also getting value that is about to resume a momentum price trajectory. The exaggerated reports of a great stock's death are often terrific "one shot, one kill" trading opportunities. Here are my essential screening gauntlet for "killer" swing trades with an edge: 1) Industry Dominator, Moat Optional
2) Earnings Machine with Institutional Sponsorship
3) Juicy Price Collapse that makes me say: "This stock is on sale!" The first criterion is pretty straight forward. I want to be looking at a well-run business with an established niche, if not industry domination. Obviously, a competitive moat is ideal. It's hard to get excited about price momentum if the company doesn't have other kinds of momentum going for it. The second criterion is all about growth. And when steady earnings momentum is confirmed by institutional investors accumulating and holding shares over long periods, you know you are in good company for higher prices in early to mid-stage growth. The third criterion is all about relative value. Sometimes good stocks get trashed for some of the following unwarranted reasons: Missed EPS or revenue target
Warned about a soft patch in business or economy
Made an acquisition the Street didn't like
New competitor is knocking on their niche
Concerns about the economy that cause a correction and sink all stocks with the market tide
Management change or a legal/regulatory/environmental battle cry from some assailant The assault could be any one of a dozen things that drive the price of a good company down 20% or more. In all cases, if you can confirm that criterion #1 and #2 are still intact, you may have just found a juicy bargain.
--------------------------------------------------------------------------------- Only Hours to Go for Hidden Bulls Saturday, February 18 is your last chance to target quick bull market swings that few are seeing. Time's running out to take advantage of the irrational behavior of other investors. The door must close to Zacks' new short-term investor group because if too many members were accepted, it would be harder for everyone to profit fully. Don't miss four powerful investment opportunities that are emerging... See them now >> ---------------------------------------------------------------------------------
3 Stocks That Screamed "Buy Me!"
1) CME Group ( CME )
The most dominant derivatives exchange in the world saw a slow drift lower in its shares for all of 2011. Falling from above $325 to support at $240 in the fall, the stock met strong resistance at its 200-day moving average in November at $280. And then things really got scary when one of its largest clearing members filed for bankruptcy on Halloween. The implosion of MF Global sent institutional investors running for the hills, and sent the stock to lows not seen since April of 2009. When I saw the stock trading at $225 in early January, I decided to take a closer look at the earnings picture. Estimates had definitely come down after the Corzine debacle, but the core business was intact, still dominant and still growing. Plus, the company was poised for potentially outstanding growth as trillions in the OTC interest rate derivatives business was destined to move to the exchange "mark-to-market" model. Sensing a fantastic opportunity, I bought March 260 calls for under $2.50. After CME's strong earnings report in February, the stock exploded from $240 to $290, handing my Tactical Trader subscribers at least a triple (200% gain) in those options, while some held on to see ten times their money!

2) Coinstar ( CSTR ) Remember when Netflix ( NFLX ) shot themselves in the foot by making their subscriber service more complicated and costly? Customers said "who needs this?" And investors punished the stock because they saw the company headed in all the wrong directions. Well a tiny little competitor for movie entertainment appeared to be headed down the same path after its October earnings report. Coinstar, owner of the Redbox DVD rental kiosks, raised their price by a whole 20 cents! The stock fell nearly 20% as investors thought it was another NFLX debacle. I said this was crazy! This price bump should only make CSTR earnings estimates go up. And everybody I knew who rented movies the Redbox way would gladly pay another 20 cents. Heck, most people I know would pay another buck and not think twice. Why? Because it's fun to go pick a flick that way - even if you are "streaming" video at home, which most consumers are not. I was so convinced about CSTR being a bargain, I told everyone to "buy it with both hands" under $45. The company was not only executing its core strategy, it was brewing the content distribution deal with Verizon for potential streaming opportunities. As you can see from the chart, CSTR caught a lot of bears by surprise on their last earnings report in early February. I made 24% on my shares.

3) Vertex Pharmaceuticals ( VRTX ) Vertex is not exactly a "dominator" in biotech when compared to Amgen or Celgene. But it did create something incredible last year that surprised lots of pharma experts and investors. They produced the first incredibly successful drug treatment for the hepatitis-C virus (HCV). Their drug Incivek topped sales of over $400 million in the third quarter of 2011, while pharma giant Merck could only do about $80 million in sales with their HCV treatment. Based on this success, the earnings estimates for Vertex soared to above $4 per share for 2012 with projected sales of over $2.5 billion. But the stock was already in a curious collapse before and after those results came out, getting cut in half from $52 to $26 in only two months. I decided to take a closer look at the catalysts. What I found was that the analyst community and large biotech investors were looking at all kinds of new competition for Incivek coming to market. The VRTX drug used an interferon cocktail regime with nasty side effects and lots of competitors were creating next-generation oral treatments that didn't need interferon. The biggest threat came from Gilead Sciences who had just paid $10 billion for Pharmasett to get their hands on that young biotech's HCV treatment. The problem was that none of these competitors would have their drugs ready for market until 2014. So with 170 million people worldwide exposed to HCV, and VRTX estimates not coming down, I thought that Incivek still would win in 2012. Plus, VRTX had a cystic fibrosis drug very close to FDA approval. On the very first day of the Tactical Trader service in early December, we opened the books by buying the VRTX April 30 calls for under $4. We just sold them for a 100% gain last week. Too bad we didn't keep them a little longer as the stock launched above my $40 price target Friday morning.

Catching Falling Knives, or Scooping Fallen Gems? There's an old adage in trading and investing that one can get really hurt trying to catch a falling knife. But if you do your homework, and you develop sound screening criteria that give you a very favorable risk/reward edge, you can bank sizable profits off the irrationality of other investors. I may not have the deep pocket and time horizon of a Warren Buffett, but my approach fully capitalizes on the idea to "be greedy when others are fearful."
No Need to Pursue These Profits on Your Own If you'd like some help, my private trading group has been re-opened until Saturday to new investors. Its purpose is to go long or short with stock, ETF, and options moves to catch small market swings that others rarely spot and ride them for substantial one to 12-week gains. The number of investors who share the moves from our Zacks Tactical Trader must be limited, and demand to get into the service was so intense that it had to be closed early when introduced last December. Now it's open to you again, but only until 11:59 pm Saturday, February 18. There will be no extensions so I strongly encourage you to look into it now. Click now for details about Tactical Trader >> Good Investing, Kevin Cook Kevin, a Senior Stock Strategist at Zacks, is a recognized authority in global markets. A former market-maker in the $4-trillion-dollar-a-day world of interbank trading, he developed the ability to track the movement of money, and trained his reflexes to take advantage of it. Today he directs the new Zacks Tactical Trader , providing commentary and recommendations.
 
CME GROUP INC ( CME ): Free Stock Analysis Report
 
COINSTAR INC ( CSTR ): Free Stock Analysis Report
 
VERTEX PHARM ( VRTX ): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Continue reading here:
3 Killer Criteria for Super Swing Trades - Weekend Wisdom

How do you find good stocks for great short-term trading opportunities? Do you hunt for value, growth or price momentum?

I look for all three, but with a twist that gives me an added 'edge'. I want to buy solid growth stocks after the market has 'temporarily' and irrationally thrown them out with the bath water. If I am right that the selling insanity is temporary, I am also getting value that is about to resume a momentum price trajectory.

The exaggerated reports of a great stock's death are often terrific 'one shot, one kill' trading opportunities. Here are my essential screening gauntlet for 'killer' swing trades with an edge:

1) Industry Dominator, Moat Optional
2) Earnings Machine with Institutional Sponsorship
3) Juicy Price Collapse that makes me say: 'This stock is on sale!'

The first criterion is pretty straight forward. I want to be looking at a well-run business with an established niche, if not industry domination. Obviously, a competitive moat is ideal. It's hard to get excited about price momentum if the company doesn't have other kinds of momentum going for it.

The second criterion is all about growth. And when steady earnings momentum is confirmed by institutional investors accumulating and holding shares over long periods, you know you are in good company for higher prices in early to mid-stage growth.

The third criterion is all about relative value. Sometimes good stocks get trashed for some of the following unwarranted reasons:

Missed EPS or revenue target
Warned about a soft patch in business or economy
Made an acquisition the Street didn't like
New competitor is knocking on their niche
Concerns about the economy that cause a correction and sink all stocks with the market tide
Management change or a legal/regulatory/environmental battle cry from some assailant

The assault could be any one of a dozen things that drive the price of a good company down 20% or more. In all cases, if you can confirm that criterion #1 and #2 are still intact, you may have just found a juicy bargain.

---------------------------------------------------------------------------------

Only Hours to Go for Hidden Bulls

Saturday, February 18 is your last chance to target quick bull market swings that few are seeing. Time's running out to take advantage of the irrational behavior of other investors. The door must close to Zacks' new short-term investor group because if too many members were accepted, it would be harder for everyone to profit fully.

Don't miss four powerful investment opportunities that are emerging...

See them now >>

---------------------------------------------------------------------------------

3 Stocks That Screamed 'Buy Me!'

1) CME Group (NasdaqGS:CME - News)

The most dominant derivatives exchange in the world saw a slow drift lower in its shares for all of 2011. Falling from above $325 to support at $240 in the fall, the stock met strong resistance at its 200-day moving average in November at $280. And then things really got scary when one of its largest clearing members filed for bankruptcy on Halloween.

The implosion of MF Global sent institutional investors running for the hills, and sent the stock to lows not seen since April of 2009. When I saw the stock trading at $225 in early January, I decided to take a closer look at the earnings picture. Estimates had definitely come down after the Corzine debacle, but the core business was intact, still dominant and still growing.

Plus, the company was poised for potentially outstanding growth as trillions in the OTC interest rate derivatives business was destined to move to the exchange 'mark-to-market' model. Sensing a fantastic opportunity, I bought March 260 calls for under $2.50. After CME's strong earnings report in February, the stock exploded from $240 to $290, handing my Tactical Trader subscribers at least a triple (200% gain) in those options, while some held on to see ten times their money!

2) Coinstar (NasdaqGS:CSTR - News)

Remember when Netflix (:NFLX) shot themselves in the foot by making their subscriber service more complicated and costly? Customers said 'who needs this?' And investors punished the stock because they saw the company headed in all the wrong directions.

Well a tiny little competitor for movie entertainment appeared to be headed down the same path after its October earnings report. Coinstar, owner of the Redbox DVD rental kiosks, raised their price by a whole 20 cents! The stock fell nearly 20% as investors thought it was another NFLX debacle.

I said this was crazy! This price bump should only make CSTR earnings estimates go up. And everybody I knew who rented movies the Redbox way would gladly pay another 20 cents. Heck, most people I know would pay another buck and not think twice. Why? Because it's fun to go pick a flick that way - even if you are 'streaming' video at home, which most consumers are not.

I was so convinced about CSTR being a bargain, I told everyone to 'buy it with both hands' under $45. The company was not only executing its core strategy, it was brewing the content distribution deal with Verizon for potential streaming opportunities. As you can see from the chart, CSTR caught a lot of bears by surprise on their last earnings report in early February. I made 24% on my shares.

3) Vertex Pharmaceuticals (NasdaqGS:VRTX - News)

Vertex is not exactly a 'dominator' in biotech when compared to Amgen or Celgene. But it did create something incredible last year that surprised lots of pharma experts and investors. They produced the first incredibly successful drug treatment for the hepatitis-C virus (:HCV). Their drug Incivek topped sales of over $400 million in the third quarter of 2011, while pharma giant Merck could only do about $80 million in sales with their HCV treatment.

Based on this success, the earnings estimates for Vertex soared to above $4 per share for 2012 with projected sales of over $2.5 billion. But the stock was already in a curious collapse before and after those results came out, getting cut in half from $52 to $26 in only two months. I decided to take a closer look at the catalysts.

What I found was that the analyst community and large biotech investors were looking at all kinds of new competition for Incivek coming to market. The VRTX drug used an interferon cocktail regime with nasty side effects and lots of competitors were creating next-generation oral treatments that didn't need interferon. The biggest threat came from Gilead Sciences who had just paid $10 billion for Pharmasett to get their hands on that young biotech's HCV treatment.

The problem was that none of these competitors would have their drugs ready for market until 2014. So with 170 million people worldwide exposed to HCV, and VRTX estimates not coming down, I thought that Incivek still would win in 2012. Plus, VRTX had a cystic fibrosis drug very close to FDA approval.

On the very first day of the Tactical Trader service in early December, we opened the books by buying the VRTX April 30 calls for under $4. We just sold them for a 100% gain last week. Too bad we didn't keep them a little longer as the stock launched above my $40 price target Friday morning.

Catching Falling Knives, or Scooping Fallen Gems?

There's an old adage in trading and investing that one can get really hurt trying to catch a falling knife. But if you do your homework, and you develop sound screening criteria that give you a very favorable risk/reward edge, you can bank sizable profits off the irrationality of other investors.

I may not have the deep pocket and time horizon of a Warren Buffett, but my approach fully capitalizes on the idea to 'be greedy when others are fearful.'

No Need to Pursue These Profits on Your Own If you'd like some help, my private trading group has been re-opened until Saturday to new investors. Its purpose is to go long or short with stock, ETF, and options moves to catch small market swings that others rarely spot and ride them for substantial one to 12-week gains. The number of investors who share the moves from our Zacks Tactical Trader must be limited, and demand to get into the service was so intense that it had to be closed early when introduced last December. Now it's open to you again, but only until 11:59 pm Saturday, February 18. There will be no extensions so I strongly encourage you to look into it now. Click now for details about Tactical Trader >> Good Investing, Kevin Cook Kevin, a Senior Stock Strategist at Zacks, is a recognized authority in global markets. A former market-maker in the $4-trillion-dollar-a-day world of interbank trading, he developed the ability to track the movement of money, and trained his reflexes to take advantage of it. Today he directs the new Zacks Tactical Trader, providing commentary and recommendations.

Read the analyst report on CME

Read the analyst report on CSTR

Read the analyst report on VRTX

Zacks Investment Research

More From Zacks.com

Link:
3 Killer Criteria for Super Swing Trades